Stafford R S, Saglam D, Causino N, Blumenthal D
Health Policy Research and Development Unit, Massachusetts General Hospital, Boston 02114, USA.
Am J Obstet Gynecol. 1997 Aug;177(2):381-7. doi: 10.1016/s0002-9378(97)70202-3.
Our objective was to determine national rates and predictors of hormone replacement therapy. We analyzed a nationally representative sample of 6341 office visits by women aged > or = 40 years to primary care physicians in the 1993 and 1994 National Ambulatory Medical Care Surveys. Independent predictors of estrogen use were determined by logistic regression. Time trends from 1989 through 1994 also were evaluated. Hormone replacement therapy was documented in 4.7% of visits in 1989 to 1990 and 8.0% in 1993 to 1994. In 1993 to 1994 women with menopausal symptoms were six times more likely to have hormone replacement reported. In the absence of symptoms, obstetrician-gynecologists were nearly four times as likely to report hormone replacement therapy. Age 50 to 59 years, white race, osteoporosis, hyperlipidemia, and residence in the West and in nonmetropolitan areas also independently-predicted hormone replacement. Low rates of estrogen therapy by non-obstetrician-gynecologists and substantial practice variations suggest missed opportunities for hormone replacement therapy.
我们的目标是确定全国范围内激素替代疗法的使用率及其预测因素。我们分析了1993年和1994年全国门诊医疗调查中年龄≥40岁女性到初级保健医生处就诊的6341次门诊的全国代表性样本。通过逻辑回归确定雌激素使用的独立预测因素。还评估了1989年至1994年的时间趋势。1989年至1990年,4.7%的就诊记录了激素替代疗法,1993年至1994年为8.0%。1993年至1994年,有更年期症状的女性接受激素替代疗法的可能性是无更年期症状女性的六倍。在没有症状的情况下,妇产科医生报告激素替代疗法的可能性几乎是其他医生的四倍。年龄在50至59岁、白人种族、患有骨质疏松症、高脂血症以及居住在西部和非大都市地区也独立预测了激素替代疗法的使用。非妇产科医生的雌激素治疗率较低以及存在显著的实践差异表明激素替代疗法存在未被利用的机会。